Biogen (BIIB)

Biogen (BIIB) Financial Statements


Biogen Financial Overview

Biogen's market cap is currently ―. The company's EPS TTM is $18.364; its P/E ratio is 14.00; Biogen is scheduled to report earnings on October 24, 2023, and the estimated EPS forecast is $3.97. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 1.85B$ 1.76B$ 2.54B$ 2.51B$ 2.59B
Gross Profit$ 1.97B$ 1.69B$ 1.97B$ 2.04B$ 2.11B
EBIT$ 757.20M$ 375.80M$ 658.60M$ 1.43B$ 1.34B
EBITDA$ 874.60M$ 488.10M$ 833.60M$ 1.55B$ 1.47B
Net Income Common Stockholders$ 591.60M$ 387.90M$ 550.40M$ 1.13B$ 1.06B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.08B$ 5.04B$ 4.89B$ 4.91B$ 4.80B
Total Assets$ 25.16B$ 24.60B$ 24.55B$ 24.85B$ 25.08B
Total Debt$ 6.59B$ 6.61B$ 6.61B$ 6.63B$ 7.55B
Net Debt$ 510.70M$ 1.57B$ 1.72B$ 1.72B$ 2.75B
Total Liabilities$ 10.70B$ 10.81B$ 11.17B$ 12.09B$ 13.22B
Stockholders Equity$ 14.47B$ 13.80B$ 13.40B$ 12.78B$ 11.87B
Cash Flow-
Free Cash Flow$ 400.00M$ 383.70M$ -262.40M$ 601.90M$ 697.70M
Operating Cash Flow$ 487.00M$ 455.30M$ -175.00M$ 661.00M$ 736.50M
Investing Cash Flow$ -753.50M$ -953.00M$ -141.10M$ 1.67B$ 693.50M
Financing Cash Flow$ -9.80M$ -43.40M$ -7.40M$ -1.25B$ -471.50M
Currency in USD

Biogen Earnings and Revenue History

Biogen Debt to Assets

Biogen Cash Flow

Biogen Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis